Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

plied by such forward-looking statements. Actual results could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward-looking statements contained in this press release. In particular, there can be no guarantee that additional information relating to the safety, efficacy or tolerability of satraplatin may be discovered upon further analysis of data from the SPARC trial or analysis of additional data from other ongoing clinical trials for satraplatin. Furthermore, we cannot guarantee that satraplatin will be approved for marketing in a timely manner, if at all, by regulatory authorities nor that, if marketed, satraplatin will be a successful commercial product. We direct you to GPC Biotech's Annual Report on Form 20-F for the fiscal year ended December 31, 2005, Pharmion's Annual Report on Form 10-K for the fiscal year ended December 31, 2006 and other reports filed with the U.S. Securities and Exchange Commission for additional details on the important factors that may affect the future results, performance and achievements of either GPC Biotech or Pharmion. Forward-looking statements speak only as of the date on which they are made and neither GPC Biotech nor Pharmion undertakes any obligation to update these forward-looking statements, even if new information becomes available in the future.

The scientific information discussed in this press release related to satraplatin is investigative. Satraplatin has not yet been approved by the FDA in the U.S., the EMEA in Europe or any other regulatory authority and no conclusions can or should be drawn regarding its safety or effectiveness. Only the relevant regulatory authorities can determine whether satraplatin is safe and effective for the use(s) being investigated.

CONTACT: Breanna Burkart, or Anna Sussman, Directors, Investor Relationsand Corporate Communications, both of Pharmion Corporation,+1-720-564-9150; or Martin Braendle, Director,
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:4/1/2015)... 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... the development and commercialization of a once-daily, oral ... cholesterol gallstones, today announced that it has appointed ... Clinical Operations. Mr. Tonelli brings 20+ ... and regulatory affairs.  From 2005 to 2014, Mr. ...
(Date:4/1/2015)... Columbia and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... Erich Mohr , Ph.D., R.Psych., to its Board ... Mohr has close to two decades of biotechnology experience ... chief executive officer and board member, including serving as ...
(Date:4/1/2015)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... of the tender offer (the "Offer") by a subsidiary ... the outstanding shares of Salix Pharmaceuticals, Ltd. (NASDAQ: ... share in cash, without interest, less any applicable withholding ... April 1, 2015.  Valeant expects to complete today the ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 4Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 3
... 2011 Cytta Corp (OTCQB: CYCA) is pleased to ... client installation and deployment of our remote medical monitoring ... full scale roll out of its technology, concentrating initially ... as: Health Plans, Managed Care Organizations, Health Delivery Organizations, ...
... .decimal, Inc. (pronounced dot decimal), an innovative manufacturer of ... received 510(k) clearance from the FDA to market electron ... are now available to radiation oncology centers across the ... also known as electron ,cutouts, by radiation therapy departments ...
Cached Medicine Technology:First Client Installation of CyttaConnect™ Medical Monitoring System 2First Client Installation of CyttaConnect™ Medical Monitoring System 3Florida Medical Device Manufacturer Announces New Product Release for Radiation Therapy 2
(Date:4/1/2015)... (PRWEB) April 01, 2015 SkillSurvey, the ... in the talent lifecycle, and the premiere provider of ... Series will feature a webinar on “Using Big Data ... the chief human resources officer of MorseLife, a nationally ... for seniors and their families in Palm Beach County. ...
(Date:4/1/2015)... 01, 2015 Skin cancer is one of ... if caught early. Forefront Dermatology and Dermatology Associates of Wisconsin ... condition before it spreads so they are hosting a free ... from 8:30am - 12:30pm. , “If we can see ... of concern, that could become cancerous,” said Dr. Ken Katz, ...
(Date:4/1/2015)... 2015 It is the meat that has ... now found wrapped around other foods, infused into cocktails and ... meat candy, the gateway meat for vegetarians and the perfect ... North American Meat Institute (NAMI) has developed a new ... of a bacon processing plant and companion brochure ...
(Date:4/1/2015)... 01, 2015 Nike Tennis Camps will ... and girls ages 10-17, providing campers with the opportunity ... will experience all 4 Grand Slam surfaces on 22 ... of Great Britain’s Davis Cup team and national governing ... Richmond Park, the National Tennis Centre is the perfect ...
(Date:4/1/2015)... UT (PRWEB) April 01, 2015 Pricing Healthcare ... the last several months, bring coverage to a third of ... the states of Massachusetts, Kansas, and Iowa, and the first dedicated ... imaging center in Dallas, TX was also added. , In addition, ... Traffic to and general interest in the platform continue to grow ...
Breaking Medicine News(10 mins):Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3
... health problems outside the lungs, researchers say , , WEDNESDAY, ... and long-term toxic effects on the heart and blood ... cause death, a new report says. , The ... issue of the Journal of the American College ...
... Physician Accuracy And ... Reduces Radiation Exposure for Patients, AUSTIN, Texas, Aug. ... Institute (TCAI) at St. David,s Medical Center became,the first ... -- an enhancement to the state-of-the art Hansen Robotic ...
... ("Assurant"),(NYSE: AIZ ), a premier provider of ... that Jane Meyer,has been appointed senior vice president, ... vice president, organizational development and,corporate communications effective immediately. ... and Mr. Walker will continue to report to ...
... Daily Dietary Supplements to Introduce Fashion Week ... Survival Kit at Verrier Runway Show, ... its,first-ever fashion partnership with breakout designer Ashleigh Verrier to,promote "Style ... healthy beauty during one of the most exciting and fast-paced,fashion ...
... the National Institutes of Health (NIH) have found a mechanism ... the development of autoimmune disease when turned off. The findings ... of autoimmunity and could also have implications for the development ... as cancer and HIV. The study paper appears online today ...
... strength, agility tied to brain damage, even in the ... -- Physical frailty among the elderly may be linked ... patients develop dementia, new research reveals. , The finding, ... the notion that motor impairment in the elderly is ...
Cached Medicine News:Health News:Air Pollution Can Damage Heart, Blood Vessels, Too 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures 3Health News:Assurant Announces Two Executive Appointments 2Health News:VIACTIV(R) Partners With Rising Fashion Label Verrier to Launch 'Style and Strength for Life' Health Initiative at Fall Fashion Week 2008 2Health News:VIACTIV(R) Partners With Rising Fashion Label Verrier to Launch 'Style and Strength for Life' Health Initiative at Fall Fashion Week 2008 3Health News:NIH scientists find a novel mechanism that controls the development of autoimmunity 2Health News:Physical Frailty Could Predict Alzheimer's Disease 2Health News:Physical Frailty Could Predict Alzheimer's Disease 3
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
Medicine Products: